Skip to content

An MRI-validated study of Electrical Coupling Index catheter superiority in AF ablation – pre study

An MRI-validated study of Electrical Coupling Index catheter superiority in AF ablation – pre study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28416
Enrollment
10
Registered
2013-12-20
Start date
2014-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation DE-MRI Ablation

Interventions

PVI using electrical coupling information (one side of PV's) or using no celectrical coupling information (other side of PV's)

Sponsors

Medisch Spectrum Twente Enschede
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • Paroxysmal atrial fibrillation for which &#8805; 1 electrical and/or chemical cardioversions and persistent atrial fibrillation, eligible for PVI according to current international guidelines. • Age < 70 years. • Willing and able to sign informed consent. • Willing to and capable of following the requested study procedures.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • Age < 18 years. • Pregnancy • Life or follow-up expectancy < 12 months. • Previous PVI in history. • Contrast allergy. • Creatin clearance level lower than 60. • MRI scanning not possible (e.g. because of metal implant or claustrophobia). • Unsuccessful PVI during first procedure, while already in study. This will lead to exclusion after randomisation. • Abnormal left atrium anatomy defined as number of PV’s &#8800; 4 . This will lead to exclusion after inclusion but before randomisation.

Design outcomes

Primary

MeasureTime frame
To perform a pre-study to assess the feasibility of DE-MRI to assess lesion size, transmurality and completeness of PVI. The study will be performed to determine if and how DE-MRI can be used in a subsequent multicentre study (MERCI-AF study).

Secondary

MeasureTime frame
To collect data on the use of ECI-feedback which could be included in the MERCI-AF study.

Contacts

Public ContactJ.M. Opstal, van

Department of Cardiology Medisch Spectrum Twente Haaksbergerstraat 55

j.vanopstal@mst.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)